BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2025 12:56:13 AM | Browse: 249 | Download: 715
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 111171
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimens
Manuscript Source Unsolicited Manuscript
All Author List Si-Jia Li, Yi-Xuan Lu, Fang-Yue Zheng, Yi-Cong Bian, Li-Yan Miao and Chen-Rong Huang
ORCID
Author(s) ORCID Number
Chen-Rong Huang http://orcid.org/0000-0002-7994-0323
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China U24A20765, T2321005
Jiangsu Provincial Science and Technology Plan Special Fund BM2023003
Jiangsu Provincial Medical Key Discipline ZDXK202247
Priority Academic Program Development of the Jiangsu Higher Education Institutes
Jiangsu Engineering Research Center on Drug Evaluation and Translation of Organoids/Organ Chip (2024)
Science and Technology Plan of Suzhou SKYD2023183
Research Project Established by Chinese Pharmaceutical Association Hospital Pharmacy Department CPA-Z05-ZC-2023002
Gusu Health Talent Research Project GSWS2022015
Corresponding Author Chen-Rong Huang, PhD, Department of Pharmacy, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou 215006, Jiangsu Province, China. huangchenrong@suda.edu.cn
Key Words Colorectal cancer; Precision oncology; Adenosine triphosphate-based tumour chemotherapy sensitivity test; Clinical prediction model; Chemosensitivity; 5-fluorouracil; Oxaliplatin
Core Tip In this study, retrospectively evaluated the clinical application of adenosine triphosphate-based tumour chemotherapy sensitivity test (ATP-TCA) and revealed that it is an independent prognostic factor for disease-free survival in patients with resectable colorectal cancer. Additionally, an ATP-TCA-sensitive chemotherapy regimen was shown to significantly improve overall survival and disease-free survival in colorectal patients in stage III. Although the necessity for further validation, this study provides evidence supporting the extension of ATP-TCA assays to combination chemotherapy regimens for colorectal cancer while providing a theoretical basis and perspective for future advancements in personalized medicine.
Publish Date 2025-11-14 00:56
Citation

Li SJ, Lu YX, Zheng FY, Bian YC, Miao LY, Huang CR. Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimens. World J Gastrointest Oncol 2025; 17(11): 111171

URL https://www.wjgnet.com/1948-5204/full/v17/i11/111171.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i11.111171
Full Article (PDF) WJGO-17-111171-with-cover.pdf